NCT03815344View on ClinicalTrials.gov

Combined Vaginal Misoprostol and Perivascular Vasopressin

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
LeiomyomaLaparoscopyUterine Myomectomy
Interventions
DRUG

Standard

20 units diluted in 100mL of Normal Saline injected laparoscopic needle

DRUG

Standard-vaginal misoprostol

20 units diluted in 100mL of Normal Saline injected laparoscopic needle and misoprostol 400 mcg

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER

NCT03815344 - Combined Vaginal Misoprostol and Perivascular Vasopressin | Biotech Hunter | Biotech Hunter